Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: A Phase III, randomized, double-blind, placebo-controlled study

Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Taro Muramatsu, Hidetomo Nakamoto, Hiromichi Suzuki

Research output: Contribution to journalArticlepeer-review

187 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: A Phase III, randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences